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massively parallel reporter assays
Soo Bin Kwon1,2 and Jason Ernst1,2,3,4,5,6*Abstract
A recent study in Genome Biology has characterized the
evolution of candidate hominoid-specific liver enhancers
by using massively parallel reporter assays (MPRAs).work on the application of MPRA technology to evolu-Introduction
Enhancers play a key role in cell-type-specific gene regu-
lation, and their disruption has been associated with hu-
man disease [1, 2]. Although enhancers do show
enrichment for evolutionarily conserved sequences, they
are substantially less conserved than protein-coding se-
quences. Their faster evolution at the sequence level
suggests that changes to enhancers are an important
source of phenotypic differences between closely related
species such as human and other primates.
Previous work has moved beyond studying enhancer
evolution at the sequence level by mapping enhancer-
associated histone modifications across species. One
notable such study mapped the active enhancer-
associated modification of histone H3 lysine 27 acetyl-
ation (H3K27ac) in liver for 20 mammals, including
human and three other primates, using chromatin im-
munoprecipitation with sequencing (ChIP-seq) [3]. The
study observed rapid evolution of liver enhancers in
mammals. Now new work by Klein and colleagues [4]
seeks to further understand the evolution of candidate
hominoid-specific liver enhancers identified based on
ChIP-seq data. To achieve a deeper understanding of the
evolution of enhancers than is possible from ChIP-seq
data alone, the authors have made effective use of mas-
sively parallel reporter assays (MPRAs).
MPRAs allow simultaneous quantification of thou-
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range of applications to study enhancers, including test-
ing potential phenotypic-associated common genetic
variants [2] and identifying activating and repressive
nucleotides within them [5–7]. In previous pioneering
tion, Arnold and colleagues used self-transcribing active
regulatory region sequencing (STARR-seq) [8], a specific
type of MPRA, to compare genome-wide enhancer
activity in five Drosophila species [9]. However, applica-
tion of MPRA to problems in evolution has remained
limited. Now Klein and colleagues demonstrate a new
application of STARR-seq in the context of evolution, in
this case to give a detailed high-resolution view of the
evolution of hundreds of enhancers across primates.Functional testing of the human sequence of
candidate hominoid-specific liver enhancers
Klein and colleagues first identified a candidate set of
hominoid-specific liver enhancers based on enrichment of
H3K27ac in ChIP-seq data from human liver, but lack of the
enrichment in rhesus, vervet, and marmoset monkeys, in
addition to lack of enrichment with the promoter-associated
histone H3 lysine 4 tri-methylation (H3K4me3) mark in hu-
man. They then sought to test a subset of these sequences
with the STARR-seq assay in experimentally tractable hu-
man HepG2 cells, which are liver hepatocellular carcinoma
cells. The authors restricted their testing to the subset of
candidate hominoid-specific liver enhancers that also over-
lapped strong enhancer chromatin-state predictions in
HepG2 cells by the ChromHMM method [1]. As the se-
quences they could synthesize for testing were 194 nucleo-
tides in length, which was smaller than the enhancer regions
predicted based on ChIP-seq, they tiled the enhancer re-
gions with tiles overlapping by approximately 100 base pairs.
This identified hundreds of enhancers showing activity at
one or more tiles, with approximately one-third of tested
predicted enhancers showing activity for at least one tile.
Focusing on the subset of tiles in human that had
orthologous sequences in ten other primates, Klein et al.le is distributed under the terms of the Creative Commons Attribution 4.0
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the enhancers being active in human, but less active in
other primates. When comparing the human and ortho-
logous marmoset sequence, they found some preferential
enrichment for motifs for several liver-associated tran-
scription factors. However, when attempting to predict
the difference of activity among orthologous sequences
in human and other primates based on a gapped k-mer
support vector machine [10], they did not observe the
statistically significant reduction in predicted activity
that was expected based on ChIP-seq data. This was des-
pite demonstrating that their trained classifier was rela-
tively effective at predicting varying enhancer activity
levels within human samples.
Functional testing of orthologs of active human
enhancers throughout the primate phylogeny
The inability to predict a reduction of activity in orthologs
based on sequence motivated Klein and colleagues to dir-
ectly functionally test the sequences of other primates.
Specifically, the authors designed a new STARR-seq ex-
periment focusing on a set of tiles that were active in hu-
man and had orthologs in ten other present-day primates.
In addition to testing the human sequences and the ten
other present-day primate orthologs, the authors also
tested nine ancestral reconstructions all together in
HepG2 cells.
The experimental data revealed that only a minority of
the tested tiles showed a reduction in activity relative to
human, the expected pattern based on the liver
H3K27ac ChIP-seq data. The limited overall reduction
relative to human was also seen with the sequence-based
predictions. However, there was limited agreement be-
tween which specific tiles were predicted to have re-
duced activity based on sequence and which actually did
so in the experiments. The authors did find, however,
that the overall clustering of their experimental data was
consistent with the phylogenetic relationship among the
species. Renormalization of the experimental data rela-
tive to the oldest ancestor tested identified a number of
tiles having coherent evolutionary trajectories, which
could be explained parsimoniously by relatively few
gains or losses of activity.
CpG deamination as an important force in
enhancer evolution
Klein and colleagues then investigated associations be-
tween mutations and changes in functional activity in the
tested enhancers across primate evolution. They found a
significant, albeit modest, correlation between the number
of sequence mutations and functional divergence along
branches of the phylogeny. They then identified a set of
‘prioritized variants’ to explain significant associations be-
tween sequence and functional divergence. Among theprioritized variants, the investigators found a statistically
significant enrichment for the C-to-T and G-to-A pair of
mutations. This prompted them to test whether there was
also an enrichment for CpG deamination relative to its
background frequency, which they confirmed to be the
case. The authors thus hypothesized that CpG deamin-
ation could play an important role in primate enhancer
evolution and noted other prior supporting evidence, in-
cluding its high frequency of mutation, its efficiency at
creating new transcription factor binding sites and its abil-
ity to alter enhancer methylation patterns.Concluding remarks
This work by Klein and colleagues is an exciting demon-
stration of the power of the MPRA technology for study-
ing enhancer evolution, which has several attractive
features in this context. One attractive feature is that
DNA material from the tested species is not needed,
which allows testing of computationally reconstructed
ancestral sequences and facilitates the testing of many
present-day species. Another strength is that the assay
can simultaneously test hundreds of different enhancer
sequences across species, with the sequences tested be-
ing the same except for the species-specific individual
nucleotide differences. Furthermore, the experiment
tests all the sequences together in one common environ-
ment and thus avoids many potential experimental con-
founders. Some inferences derived from data from a
common trans environment depend on an assumption
that differences at the cis-level will be much more sub-
stantial than at the trans-level, which the authors justi-
fied based on prior studies.
Two surprising results of the authors’ study were the
limited agreement of species differences in the liver
ChIP-seq data with that of the reporter activity and the
limited ability to predict which enhancers would show
changes in activity based on sequence. Both results
underscore the greater challenge associated with predict-
ing differential activity across species compared with
absolute activity within a species. The limited agreement
between the liver ChIP-seq data and the functional activ-
ity in MPRA experiments might be due to differences
between primary liver samples and HepG2 cells. Another
possible cause of the lack of agreement could arise from
inherent differences between what ChIP-seq and MPRA
experiments measure. Furthermore, differences in the chro-
matin and extended sequence context of the experiments,
which is the native genome for ChIP-seq and a plasmid for
MPRA, might also limit agreement. The inability to predict
the activity changes based on sequence suggests opportun-
ities for improved computational models for predicting
activity changes from sequence changes or a different appli-
cation of existing approaches.
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towards a better understanding of enhancer evolution
and the relationship between sequence and functional
divergence. This study provides support for the hypoth-
esis of CpG deamination as a possible driving force for
enhancer modulation. More generally, this work pre-
sents an effective approach for investigating evolutionary
mutations in enhancers and their resulting functional
changes that should be useful to future studies in other
systems or species.
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